Infection of the CD45RA+ (Naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo

Journal of Virology

Volumn 75, Issue 9, 2001, Pages 4091-4102

  McBreen, S ^a   Imlach, S ^a   Shirafuji, T ^a   Scott, G R ^a   Leen, C ^a   Bell, J E ^a   Simmonds, P ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BINDING SITE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LONG TERMINAL REPEAT; MALE; NUCLEOTIDE SEQUENCE; ONTOGENY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROVIRUS; SEQUENCE ANALYSIS; T LYMPHOCYTE SUBPOPULATION;

AMINO ACID SEQUENCE; ANTIGENS, CD45; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DNA, VIRAL; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; MOLECULAR SEQUENCE DATA; PROVIRUSES;

EID: 0035043290     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.9.4091-4102.2001     Document Type: Article

References (54)

1. Impact on the immune system of undetectable plasma HIV-1 RNA for more than 2 years
2. Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo
3. CD4+ T-cell memory, CD45R subsets and the persistence of antigen - A unifying concept
4. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist
5. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes
6. Early effects of antiretroviral combination therapy on activation, apoptosis and regeneration of T cells in HIV-1-infected children and adolescents
7. Cellular proviral HIV type 1 DNA load persists after long-term RT-inhibitor therapy in HIV type 1 infected persons - Short communication
8. + T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment
9. + T cells to the cytopathic effects of infection with human immunodeficiency virus type 1 strain LAI
10. Minimal requirements for the human immunodeficiency virus type 1 V3 domain to support the syncytium-inducing phenotype: Analysis by single amino acid substitution
11. HIV-1 cDNA integration: Requirement of HMG I(Y) protein for function of preintegration complexes in vitro
12. + T lymphocytes through the T cell receptor turns on CD4 gene expression: Implications for HIV pathogenesis
13. Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule
14. CD8+ lymphocyte activation at human immunodeficiency virus type 1 seroconversion: Development of HLA-DR+ CD38- CD8+ cells is associated with subsequent stable CD4+ cell levels
15. + T cells
16. Detection of lymphocytes expressing human T lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridisation
17. Toward an understanding of the correlates of protective immunity to HIV infection
18. HIV infection of CD45RA+ and CD45RO+ CD4+ cells
19. + T cells is mediated by macrophages through interaction of HIV gp120 with chemokine receptor CXCR4
20. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens
21. Proteolytic fragments of anti-HIV and anti-tumor proteins MAP30 and GAP31 are biologically active
22. Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients
23. Quantification of HIV-1 proviral DNA by a standardized colorimetric PCR-based assay
24. Treatment response and durability of a double protease inhibitor therapy with saquinavir and ritonavir in an observational cohort of HIV-1-infected individuals
25. + lymphocytes induces CD4 expression and allows human immunodeficiency virus type 1 infection
26. Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: Differentiation from a CD4-positive precursor allows productive infection
27. + thymocytes
28. Pathogenesis of human immunodeficiency virus infection
29. Anergy and apoptosis in CD8+ T cells from HIV-infected persons
30. Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1
31. A new look at T cells
32. Detection of unintegrated human immunodeficiency virus type-1 DNA in persistently infected CD8+ cells
33. + T cells and monocytes from cord and adult blood
34. Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapy
35. + T cells are infec4ed in human immunodeficiency virus type 1-infected individuals
36. T cell dynamics of immunodeficiency
37. CD8 naive T cell counts decrease progressively in HIV-infected adults
38. HIV does not replicate in naive CD4 T cells stimulated with CD3/CD28
39. Activation of HIV-1 coreceptor (CXCR4) mediates myelosuppression
40. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell functional defects observed in infected individuals
41. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4
42. Analysis of sequence diversity in hypervariabie regions of the external glycoprotein of human immunodeficiency virus type 1
43. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers
44. CD4+ memory T cells are the predominant population of HIV-1-infected lymphocytes in neonates and children
45. Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro
46. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse
47. HIV-1 replication is controlled at the level of T cell activation and proviral integration
48. HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo
49. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa
50. + T lymphocytes by HIV-1
51. HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structure
52. Incompletely reverse transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle
53. Detection, quantification and sequencing of HIV-1 from the plasma of seropositive individuals and from factor VIII concentrates